850105P

20:4 Lyso PI

1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt), powder

• Synonim(y): 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-2-hydroxy-sn-glycero-3-phospho-(1′-myo-inositol); PI(20:4(5Z,8Z,11Z,14Z)/0:0)
• Wzór empiryczny (zapis Hilla): C₂₉H₅₂NO₁₂P
• Numer CAS: 1246430-04-5
• Masa cząsteczkowa: 637.70
• Kod UNSPSC: 51191904
• NACRES: NA.25

Właściwości

• Próba: >99% (LPI; may contain up to 10% of the 2-LPI isomer, TLC)
• Postać: powder
• opakowanie: pkg of 1 × 100 μg (with stopper and crimp cap (850105P-100ug)); pkg of 1 × 500 μg (with stopper and crimp cap (850105P-500ug))
• producent / nazwa handlowa: Avanti Research^™ - A Croda Brand 850105P
• typ lipidu: phospholipids
• Warunki transportu: dry ice
• temp. przechowywania: −20°C
• ciąg SMILES: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O)=O)(O)COC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O.[NH4+]

Opis

Opis ogólny

20:4 Lyso PI or 1-arachidonoyl-2-hydroxy-sn-glycero-3-phosphoinositol (ammonium salt) is an ammonium salt of phosphoinositol, with substitution of arachidonic acid at the sn-1 position of the glycerol backbone.

Increased circulating levels of L-alpha-lysophosphatidylinositol (LPI) are associated with cancer and LPI is a potent ligand for the G-protein-coupled receptor GPR55.

Zastosowanie

20:4 Lyso PI or has been used as a lipid standard for optimization of the liquid chromatography mass spectrometry (LC-MS) method conditions.

Opakowanie

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-100ug)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850105P-500ug)

Informacje prawne

Avanti Research is a trademark of Avanti Polar Lipids, LLC

This page may contain text that has been machine translated.

Informacja o środkach bezpieczeństwa

• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): No data available
• Temperatura zapłonu (°C): No data available